For research use only. Not for therapeutic Use.
Biotin-labeled Agatolimod sodium(CAT: I041010) is a biotinylated version of Agatolimod, a potent synthetic oligonucleotide that acts as a Toll-like receptor 9 (TLR9) agonist. This biotinylation allows for easy detection and quantification in a variety of experimental setups, including immunoassays and affinity capture methods. Biotin-labeled Agatolimod sodium enhances the innate immune response by stimulating TLR9, triggering the release of pro-inflammatory cytokines and activating dendritic cells, macrophages, and B cells. It has significant applications in immunotherapy research, particularly for studying cancer immunotherapy, autoimmune disease models, and vaccine development, where modulation of TLR9 can drive immune activation and improve therapeutic outcomes.
| Purity | ≥95% |
